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In Ho Chi Minh City, Vietnam, reporting rates for tu-
berculosis (TB) are rising in an emerging HIV epidemic. To 
describe the HIV epidemic among TB patients and quan-
tify its impact on rates of reported TB, we performed a re-
peated cross-sectional survey from 1997 through 2002 in 
a randomly selected sample of inner city TB patients. We 
assessed effect by adjusting TB case reporting rates by the 
fraction of TB cases attributable to HIV infection. HIV preva-
lence in TB patients rose exponentially from 1.5% to 9.0% 
during the study period. Young (<35 years), single, male pa-
tients were mostly affected; injection drug use was a potent 
risk factor. After correction for HIV infection, the trend in TB 
reporting rates changed from a 1.9% increase to a 0.4% de-
crease per year. An emerging HIV epidemic, concentrated 
in young, male, injection drug users, is responsible for in-
creased TB reporting rates in urban Vietnam.
Patients who are co-infected with HIV and Mycobacte-rium tuberculosis are at high risk for active tuberculo-
sis (TB) (1). In developing countries, such patients add to 
the load of already strained TB programs. Although the ef-
fect of HIV on the TB epidemic is extensively documented 
in sub-Saharan Africa (2), less is known about its effect 
in Southeast Asia (3,4). Although HIV rates in the gener-
al Southeast Asian population are still relatively low (5), 
many of these countries have high prevalence of latent TB 
infection, which makes them vulnerable to the effects of a 
combined epidemic.
Vietnam is listed by the World Health Organization 
(WHO) as a TB high-burden country and, through a strong 
National TB Program (NTP), has reached and exceeded the 
WHO targets of 70% case detection and 85% cure rates from 
1997 onward (6,7). As a result, TB incidence was expected 
to decline (8), but thus far this has not happened (9). One 
possible explanation for this phenomenon is HIV infection.
The fi rst case of HIV infection in Vietnam was record-
ed in 1990, and since then HIV infection has been mostly 
limited to men and high-risk groups such as injection drug 
users (IDUs) and commercial sex workers (10). In more 
recent years, however, rising HIV infection rates in TB pa-
tients have been documented in Ho Chi Minh City, the ma-
jor urban area with the highest HIV prevalence in the coun-
try (11). Since 1997, Ho Chi Minh City has also reported 
increasing TB rates, particularly for young adults (12).
Our study objective was to describe the course of the 
HIV prevalence among TB patients in Ho Chi Minh City 
during 1997–2002. By combining our data with the NTP 
reporting data, we also quantifi ed the effect of HIV on the 
TB reporting rates in this city.
Methods
Patient Enrollment
From 1997 through 2002, we performed a repeated 
cross-sectional survey of HIV prevalence among TB pa-
tients in the 12 most urbanized districts (districts 1, 3, 4, 
5, 6, 8, 10, 11, Phu nhuan, Tan binh, Nha be, and Binh 
thanh) of Ho Chi Minh City. Until 1998, districts included 
all patients >15 years of age who had confi rmed TB ac-
cording to WHO criteria and who consented to HIV testing 
during the same quarter each year. Since 1999, enrollment 
was restricted to the last quarter of the year for all districts. 
Enrollment stopped after a quota was reached; the quota 
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was proportional to the annual number of patients treated in 
the district, set to obtain a total sample size of ≈800 patients 
each year. Ethical approval was obtained from the Ho Chi 
Minh City Council Research Board.
Measurements
We determined HIV status by ELISA (Genolavia 
Mixt, Sanofi , Paris, France, until 1999; and Genscreen, 
Sanofi , Paris, France, from 1999 onward) and an indepen-
dent confi rmatory test (Serodia; Fujirebio, Tokyo, Japan, or 
Vironostika, Organon, Boxtel, the Netherlands) if the fi rst 
test result was positive. District TB staff collected data for 
each patient on TB disease (diagnostic category, treatment 
history), age, sex, marital and employment status, educa-
tion level, and risk factors for HIV infection. Patients who 
owned small businesses and seasonal workers were coded 
as “self-employed”; civil servants and patients under con-
tract (e.g., drivers), as “employed.” All data were entered 
twice in EpiInfo version 6 (Centers for Disease Control and 
Prevention, Atlanta, GA, USA), and discrepancies were 
checked against the raw data. TB reporting data were ob-
tained from NTP quarterly district reports. Sex, age, and 
distributions of urban and rural population size were inter-
polated from the results of the 1994, 1999, and 2004 cen-
sus; standard exponential population growth was assumed.
Statistical Analyses
For HIV trend analyses, we used 2-year blocks, in-
creasing group size and power of the analyses. The Cuzick 
test for trend was used to identify monovariate time trends 
in HIV prevalence (13). To compare proportions, we used 
the χ2 test.
Multivariable analysis was performed by logistic re-
gression. After transformation (squaring), time of inclusion 
could be entered as a continuous variable (χ2 for departure 
linear trend = 0.68 [df = 1], p = 0.41). Variables were in-
cluded when the likelihood ratio χ2 test was signifi cant at 
the 0.1 level.
We identifi ed multivariable time trends by entering 
time interaction variables (time of inclusion × variable x) in 
our logistic model (14,15). Compared with the baseline cat-
egory, an odds ratio (OR) >1 indicates a faster rise in HIV 
prevalence in that category, thereby identifying high-risk 
groups. For the sake of interpretability, we present the mul-
tivariable model without interaction terms or time trends.
To describe the combined epidemic outside the known 
high-risk groups, we ran the fi nal multivariable model af-
ter excluding all IDUs. The model goodness-of-fi t was as-
sessed by the Hosmer-Lemeshow test of goodness-of-fi t 
and by visual inspection of the distribution of the model 
residuals (16,17).
We used the formula p × (1 – 1/RR) to estimate the 
fraction of TB in patients that was attributable to HIV (the 
population-attributable fraction, PAF) (18). In this for-
mula, p represents the prevalence of HIV in TB patients, 
and RR represents the relative risk of active TB developing 
in patients with HIV versus in patients without HIV. The 
PAF thereby corrects for the fact that some of the TB cases 
among HIV-infected patients would also have occurred 
were the patients not HIV infected (18). Because this in-
formation cannot be known for individual patients, RR rep-
resents the average relative risk for HIV-infected patients. 
Lacking situational data, we conservatively assumed a con-
stant RR of 5 from 1997 through 2002. We based this esti-
mate on the literature and took into account the early stage 
and specifi c characteristics (focused in high-risk groups 
that overlap with TB risk factors such as injection drug use) 
of the combined epidemic in Southeast Asia (3). To test our 
assumption, the RR was also varied between 2 and 10 or 
gradually increased (from 2 to 10) over the study period to 
simulate a progressive fraction of HIV-infected patients in 
which active TB develops as a result of increased immune 
suppression.
The rate of TB observed without HIV was calculated 
as [(1 – PAF) × current TB rate]. We restricted this part of 
the analysis to new smear-positive TB patients from urban 
districts. The diagnosis of these patients’ condition is high-
ly standardized and the HIV/TB data came from urbanized 
districts, which ensured that combining the 2 datasets was 
as valid as possible. Exponential growth rates were esti-
mated by using the least squares method.
In 2002, the Ho Chi Minh City Council started a man-
datory rehabilitation program for IDUs. Because these re-
habilitation centers were not included in our surveillance, 
we quantifi ed potential resulting bias by estimating how in-
cluding 50% more IDUs in 2002 would affect our results.
Analyses were performed by using Stata version 8 
(Stata Corp., College Station, TX, USA). Excel 2003 (Mi-
crosoft Corp., Redmond, WA, USA) was used to asses the 
effect of HIV on reporting rates.
Results
HIV in TB Patients
A total of 5,701 patients consented to HIV testing 
(92% of those eligible) and were included in the study. Be-
cause of clerical error, 504 patients entered the study from 
July through December 1996. These were added to the sub-
set analyzed for 1997. Apart from IDUs, patient numbers 
in the individual risk categories were too low to be ana-
lyzed separately and were therefore added to the category 
of “other.”
HIV prevalence rose exponentially from 1997 through 
2002 (Table 1). The mean age of HIV-infected patients de-
creased from 38 (standard deviation [SD] = 10) to 27 (SD = 
8) years; the mean age of the HIV-negative group remained 
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stable at ≈39 (SD = 14). The male:female ratio was higher 
for HIV-infected (9:1) than for other TB (7:1) patients (χ2 
= 53.6 [df = 3], p<0.001). HIV prevalence in young (<35 
years) men rose to 22.3% (108/484) during 2001–2002.
The 12 districts did not differ signifi cantly in HIV 
prevalence during the study period (χ2 = 38.1 [df = 33], p = 
0.25) (data not shown). HIV prevalence in reported IDUs 
rose to 95% in 2001–2002, which accounted for 28% of all 
HIV-infected patients.
Multivariable and Time-Trend Analyses
In the multivariable analysis, when time trends and 
other interactions were disregarded, HIV infection among 
TB patients was associated with age <45 years, male sex, 
not being married or employed, and being an IDU (Table 
2). As the time-trend analyses show (Table 3), HIV preva-
lence increased faster in young (<35 years) patients, most 
prominently in the youngest age group (15–24 years), and 
in IDUs. Additional interaction (p value for excluding in-
teraction from model = 0.002) between marital status and 
sex indicated that the high HIV prevalence in single TB 
patients was mainly attributable to HIV infection among 
male patients.
When IDUs were excluded, the multivariable model 
predicted the data less well (–2 log likelihood with IDUs = 
–686.7, without = –660.2), but this exclusion affected nei-
ther the direction of the ORs nor their size in a relevant way 
(data not shown). Also, the Hosmer-Lemeshow test of good-
ness-of-fi t remained nonsignifi cant in both models (p = 0.72 
with IDUs, p = 0.69 without). Although IDUs and non-IDU 
HIV-infected patients did not differ relevantly in age, sex, or 
marital status (χ2 test, p = 0.93, 0.53, and 0.78 respectively), 
they did differ in their employment status and level of educa-
tion (χ2 test, p = 0.05 and <0.001, respectively).
TB Reporting Rates
PAF calculations show that 0.7%, 1.5%, 1.3%, 6.7%, 
9.5%, and 9.7% of reported new smear-positive TB cases 
Table 1. HIV prevalence in tuberculosis patients in Ho Chi Minh City, Vietnam, 1997–2002* 
Variable 1997–1998, % (n/N) 1999–2000, % (n/N) 2001–2002, % (n/N) p value† 
Study population 1.5 (38/2,476) 2.9 (47/1,617) 9.0 (144/1,608) <0.001
Age, y 
 <24 0.6 (2/342) 5.9 (14/239) 19.9 (53/267) <0.001
 25–34 2.0 (14/711) 3.1 (14/452) 14.4 (65/450) <0.001
 35–44 2.4 (17/719) 2.4 (11/460) 3.6 (16/439) 0.100
 45–54 0.7 (5/704) 1.7 (8/466) 2.2 (10/452) 0.020
Sex 
 Male 2.0 (35/1,749) 3.8 (43/1,139) 11.6 (134/1,158) <0.001
 Female 0.4 (3/727) 0.8 (4/478) 2.2 (10/450) 0.001
Marital status 
 Married 1.2 (19/1,538) 1.4 (14/989) 4.7 (46/975) <0.001
 Single 1.8 (14/775) 5.4 (28/521) 15.9 (87/549) <0.001
 Separated 3.1 (5/163) 4.7 (5/107) 13.1 (11/84) 0.010
Education level 
 Illiterate 1.1 (3/281) 2.0 (3/151) 9.4 (10/106) 0.001
 Primary 1.4 (18/1298) 3.8 (18/478) 10.7 (55/512) <0.001
 Secondary or higher 1.9 (17/897) 2.6 (26/988) 8.0 (79/990) <0.001
Employment status 
 Employed 0.9 (3/334) 2.3 (7/300) 5.8 (21/362) <0.001
 Self-employed 1.6 (22/1376) 2.9 (26/909) 8.6 (84/979) <0.001
 Unemployed 1.7 (13/766) 3.4 (14/408) 14.6 (39/267) <0.001
Risk group 
 Injection drug use 31.3 (5/16) 47.1 (8/17) 95.4 (41/43) <0.001
 Other 1.3 (33/2,460) 2.4 (39/1,600) 6.6 (103/1,565) <0.001
Patient history 
 New case 1.6 (33/2,018) 2.9 (39/1,338) 9.5 (129/1,358) <0.001
 Relapsed case 0.5 (1/223) 4.1 (5/122) 5.0 (6/119) 0.002
 Other‡ 1.7 (4/235) 1.9 (3/157) 6.9 (9/131) 0.030
Tuberculosis type 
 Smear-positive 1.5 (27/1,799) 3.3 (38/1,145) 8.3 (91/1,100) <0.001
 Smear-negative 0.3 (1/362) 1.5 (4/260) 5.2 (10/194) <0.001
 Extrapulmonary 3.2 (10/315) 2.4 (5/212) 13.7 (43/314) <0.001
*%, percentage of HIV-positive patients; n, no. HIV-infected patients; N, total no. patients.  
†p value for Cuzick nonparametric test for trend across time periods.  
‡Includes previously treated tuberculosis patients who did not respond to treatment, defaulted, or received their first treatment outside the National TB 
Program.
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were attributable to HIV in 1997, 1998, 1999, 2000, 2001, 
and 2002, respectively. After these cases were excluded 
from analysis, the rising trend in TB reporting rates re-
versed to a mild decline (Figure, panel A). When stratifi ed 
for sex (Figure, panel B) and age (Figure, panel C), this ef-
fect seemed limited to men and was most prominent in the 
younger age groups. Increasing the RR over time did not 
affect the results (data not shown). Adding 50% more IDU 
patients to the 2002 population enhanced the effect of HIV, 
which reduced the corrected annual growth in TB reporting 
from –0.2% to –1.2% in men and from –1.8% to –2.9% in 
young (<35 years) persons.
Discussion
Our results show that Ho Chi Minh City is faced with 
a combined HIV/TB epidemic that is concentrated and ex-
panding rapidly in young men; injection drug use is a high-
risk factor. By 2002, 1 in 10 TB patients was HIV infected, 
and 1 in 5 men <35 years of age was HIV infected. Even 
after taking into account the effect of HIV, TB case-report-
ing rates do not show the decline that is expected if directly 
observed therapy short course (DOTS) targets are met.
Although the observed trends in HIV infection 
among TB patients are cause for concern, they are not 
unexpected. Since 1996, HIV rates have been rising in 
Vietnam (10,19). After the average 6-year delay between 
HIV infection and development of active TB as an oppor-
tunistic infection (20), HIV infection rates among TB pa-
tients were expected to start rising around 2000. Also, the 
HIV epidemic has mainly affected young men, of whom a 
large proportion were suspected to have been IDUs (10). 
That this group takes the brunt of the combined epidemic 
and shows the fastest increase in TB/HIV prevalence is 
therefore understandable.
The relatively low proportion (28%) of HIV-infected 
patients who reported injection drug use leaves 72% of 
HIV-infected TB patients without a clear risk factor. This 
fi nding would suggest that HIV has moved beyond the es-
tablished risk groups and into the general population. How-
ever, the strong social stigma associated with injection drug 
use in Vietnam increases the chance of underreporting; the 
reported 28% may be lower than actual drug use. The lack 
of difference in multivariable models with and without re-
ported injection drug use, as well as the similar age, sex, 
Table 2. Multivariable model (without interaction terms and time trends) for HIV among tuberculosis patients in Ho Chi Minh City, 
Vietnam, 1997–2002* 
Variable Crude OR† (95% CI) p value‡ Adjusted OR§ (95% CI) p value‡ 
Year of inclusion 5.78 (4.2–7.9) <0.001 5.80 (4.1–8.2) <0.001
Age, y <0.001 <0.001
<24 6.16 (3.8–9.9) 5.15 (2.9–9.3) 
 25–34 4.25 (2.7–6.8) 4.16 (2.5–7.0) 
 35–44 1.94 (1.2–3.2) 1.96 (1.1–3.4) 
 >45 1 1
Sex <0.001 <0.001
 Male 5.33 (3.2–8.8) 5.79 (3.4–9.9) 
 Female 1 1
Marital status <0.001 <0.001
 Married 1 1
 Single 3.3 (2.4–4.3) 1.67 (1.2–2.4) 
 Separated 2.7 (1.7–4.5) 3.93 (2.2–7.0) 
Employment status 0.18 0.020
 Employed 1 1
 Self-Employed 1.31 (0.9–2.0) 1.62 (1.1–2.5) 
 Unemployed 1.49 (1.0–2.3) 1.97 (1.2–3.2) 
Risk category <0.001 <0.001
 Injection drug use 76.44 (45.5–128.3) 46.06 (25.3–84.0) 
 Other 1 1
*OR, odds ratio; CI, confidence interval. 
†Monovariate ORs. 
‡p-value for likelihood ratio F2 test for excluding variable from the model. 
§ORs adjusted for all variables in multivariable model. 
Table 3. Time trends for HIV among tuberculosis patients in Ho 
Chi Minh City, Vietnam, 1997–2002* 
Variable OR† (95% CI) p value‡ 
Age, y  0.001
<24 4.49 (1.3–15.3) 
 25–34 2.82 (0.9–8.6) 
 35–44 0.67 (0.2–2.3) 
 >44§ 1
Risk category 0.005
 IDU 10.56 (1.6–66.6) 
 Non-IDU§ 1
*OR, odds ratio; CI, confidence interval; IDU, injection drug user. 
†OR from time u variable in model; OR>1 indicates a faster rise in HIV 
prevalence in that category than in the baseline category.  
‡p value for likelihood ratio F2 test for excluding variable from model. 
§Baseline category. 
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and marital status distributions of IDU and non-IDU HIV-
infected patients, supports this possibility.
Under the assumption of a causal relationship between 
infection with HIV and the risk for active TB (1), PAF cal-
culations show that HIV was directly responsible for >9% 
of TB cases during the last 2 years of our study. This fi nd-
ing explains the increase of TB reporting rates, especially 
for young men.
The relevance of our data goes beyond the explanation 
of increasing TB reporting rates in Ho Chi Minh City. Dye 
et al. predicted that in settings with no HIV, reaching the 
WHO targets for DOTS would result in an annual decrease 
of >7% in TB reporting rates (8). However, correction for 
HIV only resulted in a small (0.3%) decline, showing that 
direct effect of HIV provides only partial explanation for 
the observed lack of effect of DOTS in Ho Chi Minh City. 
An additional explanation that we have not studied may be 
indirect effect of the HIV epidemic, i.e., through increased 
transmission of M. tuberculosis by HIV-infected TB pa-
tients. Although recent studies from sub-Saharan Africa 
have shown mixed results on this issue (21–23), those data 
are from settings with a generalized HIV epidemic, and the 
effect of an epidemic that is concentrated in IDUs may be 
different, especially in inner city areas.
Other explanations for the lack of decline in TB report-
ing rates in Ho Chi Minh City include private sector in-
volvement (24), internal migration, and perhaps emergence 
of the Beijing genotype (25). In addition, the case detection 
rate reported by WHO for Vietnam may overestimate that 
for Ho Chi Minh City. These explanations may apply es-
pecially to other parts of Vietnam, where a similar lack of 
decline in TB reporting rates is observed in the absence of 
high rates of HIV infection among TB patients (26).
Limitations
Apart from underreporting of risk factors, other limita-
tions may have affected our results. For patients in the dis-
tricts included in this surveillance, TB may have been diag-
nosed outside the surveillance project, e.g., in the city’s TB 
referral hospital or the private sector, which predominantly 
diagnose smear-negative and extrapulmonary TB. These di-
agnoses were reported for 29% of the patients in our study 
compared with 35% of all patients reported in Ho Chi Minh 
City over the study period. Our data may therefore under-
represent patients with smear-negative and extrapulmonary 
TB and may have underestimated or overestimated the HIV 
infection prevalence among them. Our estimates of the im-
pact of HIV infection on TB reporting rates, however, will 
not be subject to such bias because these were based on 
new smear-positive patients only.   
We have no data on levels of CD4+ lymphocytes and 
could not stage immune depletion in HIV-infected patients. 
Whether a case of TB in an HIV-infected patient was due 
to advanced immune depletion or would have occurred re-
gardless of HIV infection is thus unknown. We have dealt 
with this possible bias by applying the PAF, which mea-
sures excess cases only (27). The PAF depends on the RR 
of TB for HIV-infected persons compared with non–HIV-
infected persons and thereby on the level of immune deple-
Figure. Trends in notifi cation rates of new smear-positive 
tuberculosis (TB) cases in Ho Chi Minh City, Vietnam, observed and 
after correction for proportion of cases attributable to HIV infection. 
Total population (A), sex (B), and age specifi c (C). Correction of 
notifi cation rates based on population attributable fraction to HIV 
infection assuming a risk ratio (RR) of 5 for risk for TB among HIV-
infected compared with non–HIV-infected populations. *Error bars 
indicate corrected rates based on assumption that RR = 2 (top) 
or RR = 10 (bottom). †Exponential annual change (expressed as 
percentage) of TB notifi cation rates. 
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tion. Because no estimates of this RR are known for the 
Vietnamese setting, we assumed a value of 5, which is in 
accordance with RRs found in several studies conducted 
elsewhere (3,28,29). We also applied values of 2 and 10 
and increased the RR over the study period, simulating an 
increasingly vulnerable population. Neither affected our re-
sults in any relevant way.
The withdrawal of IDUs from regular surveillance in 
2002 may also have caused bias. But as our simulations 
showed, the absence of 50% of IDUs reduced the size of 
the effect but not its direction.
Recommendations
We recommend that in Ho Chi Minh City all TB pa-
tients be tested for HIV because detection of HIV infections 
can help prevent some of the excess deaths in this popula-
tion (cotrimoxazole preventive treatment and antiretroviral 
therapy) (30,31). To prevent active TB, prophylactic iso-
niazid treatment for HIV-infected patients could be consid-
ered (31,32). However, a recent study from Ho Chi Minh 
City showed that isoniazid resistance levels might be too 
high (>25% in new TB patients) for successful implemen-
tation (33). Highly active antiretroviral therapy is being 
introduced and is expected to reduce the risk for TB dis-
ease in HIV-infected patients (34–36). Injection drug use 
clearly remains a potent source of health problems; efforts 
to reach out to the vulnerable population of IDUs should 
be sustained and increased. In addition to the interventions 
mentioned, TB screening for HIV-infected IDUs and TB 
treatment for those found to have TB disease should be 
considered. 
Conclusions
Ho Chi Minh City is now faced with a combined HIV/
TB epidemic, predominantly among young men, which re-
duces the success of TB control. However, HIV alone does 
not fully explain the lack of a strong decline in TB report-
ing rates.
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